INTUITIVE SURGICAL INC (ISRG): 10-K filed January 31, 2025

AI analysis of the 10-K that INTUITIVE SURGICAL INC filed with the U.S. SEC on January 31, 2025, grounded in the primary-source EDGAR filing.

• Stable Financial Position: No material negative events reported in FY2024 10-K; operations and financials remain stable with no significant deterioration disclosed.

• Geopolitical Risk Exposure: International revenue (~40% of total) creates meaningful vulnerability to trade tensions and potential tariff impacts that could pressure margins and growth.

• Intensifying Competition: Increasing robotic surgery competitors pose risk to ISRG's pricing power and market dominance if rivals achieve clinical parity; competitive pressure may accelerate.

Filing analysis — key questions

Answers are generated from this SEC filing and StockHuntr's analysis. Not investment advice.

What does INTUITIVE SURGICAL INC (ISRG)'s 10-K filed January 31, 2025 say?

Company Overview: Intuitive Surgical Inc is a medical device manufacturer (SIC 3842) headquartered in Sunnyvale, CA, specializing in orthopedic, prosthetic, and surgical appliances and supplies, with fiscal year ending December 31, 2024 Business Segments: The company operates with distinct product and service revenue streams, with Systems segment representing a significant portion of operations…

Is ISRG's 10-K bullish or bearish?

Our analysis rates this filing CAUTIOUS. The elevated concern level of 6.2 reflects a company operating in a structurally attractive market with a strong competitive position, but facing meaningful headwinds that warrant investor caution. Intuitive Surgical confronts two high-severity risks…

How concerning is ISRG's latest 10-K?

Concern level: HIGH (6.2/10). Key factors: Two high-severity risks identified (Regulatory/Reimbursement Pressures and Product Liability/Clinical Safety at severity 7/10 each); Significant international revenue exposure (~40% of total) creates vulnerability to geopolitical tensions, trade restrictions, and currency fluctuations; Competitive intensity in robotic surgery market intensifying with new…

What are the main risks flagged in ISRG's 10-K?

Notable risk changes: No material new negative events disclosed in 10-K; filing appears to reflect stable operational and financial position for FY2024; International revenue concentration (~40% of total) represents ongoing geopolitical exposure, particularly given current trade tensions and potential tariff impacts; Competitive landscape remains intense with multiple new entrants in robotic surgery space; ISRG's…

About this analysis

Primary source:
View this 10-K on SEC EDGAR
Additional data:
Yahoo Finance (market data)
Method:
StockHuntr analyzes filings with AI — see our methodology.
Analysis as of:
January 31, 2025
Published by:
StockHuntr

For research and education only. Nothing here is investment advice.

📄

Fetching Filing from SEC

Downloading filing HTML from SEC.gov...

15% Complete
1
Fetch filing from SEC
2
Parse document sections
3
Fetch prior filing
4
Analyze risk factors
5
Analyze management sentiment
6
Extract financial metrics
7
Compare to analyst consensus
8
Run ML prediction model
9
Finalize analysis

Note: Analysis typically takes 30-60 seconds. We're fetching real SEC filing data and running AI analysis on the actual content.